Constipation News and Research

RSS
Constipation is a condition in which stool becomes hard, dry, and difficult to pass, and bowel movements don’t happen very often. Other symptoms may include painful bowel movements, and feeling bloated, uncomfortable, and sluggish.
Drugs approved for breast cancer treatment are effective and well tolerated in men

Drugs approved for breast cancer treatment are effective and well tolerated in men

New 17-item questionnaire may help detect GI disorders in children with autism

New 17-item questionnaire may help detect GI disorders in children with autism

Genentech’s combination therapy improves outcome in patients with non-squamous non-small cell lung cancer

Genentech’s combination therapy improves outcome in patients with non-squamous non-small cell lung cancer

Combination of Opdivo and Yervoy shows four-year survival benefits in patients with advanced melanoma

Combination of Opdivo and Yervoy shows four-year survival benefits in patients with advanced melanoma

Merck presents MK-1454 Phase 1 data for treatment of advanced solid tumors or lymphomas

Merck presents MK-1454 Phase 1 data for treatment of advanced solid tumors or lymphomas

At-home biofeedback therapy effective in relieving difficult-to-treat constipation

At-home biofeedback therapy effective in relieving difficult-to-treat constipation

LYNPARZA Phase III SOLO-1 results show improved outcome for patients with advanced BRCA-mutated ovarian cancer

LYNPARZA Phase III SOLO-1 results show improved outcome for patients with advanced BRCA-mutated ovarian cancer

Merck presents KEYNOTE-057 trial results for patients with high-risk non-muscle invasive bladder cancer

Merck presents KEYNOTE-057 trial results for patients with high-risk non-muscle invasive bladder cancer

Deciphera presents Phase 1 clinical results of DCC-2618 in patients with gastrointestinal stromal tumors

Deciphera presents Phase 1 clinical results of DCC-2618 in patients with gastrointestinal stromal tumors

New pragmatic study launched to understand the effectiveness of new type 2 diabetes drug

New pragmatic study launched to understand the effectiveness of new type 2 diabetes drug

For-profit nursing home residents more likely to experience health issues caused by substandard care

For-profit nursing home residents more likely to experience health issues caused by substandard care

Eisai enters into agreement with Eurofarma for development and sales of lorcaserin in 17 countries

Eisai enters into agreement with Eurofarma for development and sales of lorcaserin in 17 countries

Study suggests novel approach to treating adults with autism spectrum disorder

Study suggests novel approach to treating adults with autism spectrum disorder

Viruses shown to cause bowel dysfunction and abdominal pain

Viruses shown to cause bowel dysfunction and abdominal pain

Genentech announces clinical data from studies investigating risdiplam in spinal muscular atrophy

Genentech announces clinical data from studies investigating risdiplam in spinal muscular atrophy

New data highlights GPs’ vital role to support parents with feeding concerns

New data highlights GPs’ vital role to support parents with feeding concerns

Phase 3 ECHELON-2 clinical trial evaluating ADCETRIS plus CHP meets primary endpoint

Phase 3 ECHELON-2 clinical trial evaluating ADCETRIS plus CHP meets primary endpoint

Pfizer announces FDA approval of VIZIMPRO for first-line treatment of EGFR-mutated metastatic NSCLC

Pfizer announces FDA approval of VIZIMPRO for first-line treatment of EGFR-mutated metastatic NSCLC

American Cancer Society releases new cookbook for cancer patients

American Cancer Society releases new cookbook for cancer patients

Phase 1 and 2 clinical trials of entrectinib drug in ROS1-positive NSCLC show promising results

Phase 1 and 2 clinical trials of entrectinib drug in ROS1-positive NSCLC show promising results